-
When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney diseaseE O'Meara, S Verma. -
Heart Failure Outcomes With Volume-Guided ManagementJE Strobeck, J Feldschuh, WL Miller.
-
Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic AnalysisAL Beale, S Nanayakkara, L Segan et al.
-
Risk of Mortality Following Catheter Ablation of Atrial FibrillationEP Cheng, CF Liu, JW Cheung et al.
-
The year in cardiovascular medicine 2020: heart failure and cardiomyopathiesH Bueno, B Moura, P Lancellotti et al.
-
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection FractionBeale AL, Meyer P, Kaye DM et al.
-
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV TrialF Cosentino , CP Cannon , DZI Cherney et al.
-
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)DP Leong, JJV McMurray, PG Joseph et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
